Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

Deals > All

Total search results: 10392 | Ordered by Date (descending)
1 2 3 ... 102 103 104  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
RareCyte–Scienion: single-cell dispenser, 202006 supply existent of cellenONE to RareCyte for CTC analysis technology by Cellenion 2020-06-22
Univ Bochum–Max Planck: antibiotics research, 202006– collab establishment CESAR Center for Antibiotics Research at Univ Bochum with LDC 2020-06-18
Univ Bochum–North Rhine-Westphalia (govt): grant, 202006– grant €4m from NRW + EFRO for establishment CESAR Center for Antibiotics Research with LDC 2020-06-18
China Grand Pharma–eTheRNA: mRNA technology, 202006– collab outline terms of potential strategic partnership R+D + production + sales in Greater China 2020-06-16
DiogenX–Advent France Biotechnology: investment, 202006 seed financing round totalling €4.5m incl investor Advent France Biotechnology 2020-06-16
DiogenX–Andrew Lloyd Associates: public relations, 202006 service existent by ALA 2020-06-16
DiogenX–Boehringer: investment, 202006 seed financing round totalling €4.5m incl investor BIVF 2020-06-16
DiogenX–Juvenile Diabetes Research Foundation: investment, 202006 seed financing round totalling €4.5m incl investor JDRF T1D Fund 2020-06-16
DiogenX–SEVERAL: investment, 202006 seed financing round €4.5m from Advent France Biotechnology + BIVF + JDRF T1D Fund 2020-06-16
eTheRNA–BNP Paribas: investment, 202006 financing round Series B totalling €34m incl new investor BNP Paribas Fortis Equity 2020-06-16
eTheRNA–Boehringer: investment, 202006 financing round Series B totalling €34m incl existing investor BIVF 2020-06-16
eTheRNA–China Grand Pharma: investment, 202006 financing round Series B totalling €34m incl new investor Grand Decade 2020-06-16
eTheRNA–Flanders (govt): investment, 202006 financing round Series B totalling €34m incl existing investor PMV 2020-06-16
eTheRNA–Fund+: investment, 202006 financing round Series B totalling €34m incl existing investor Fund+ 2020-06-16
eTheRNA–Life Sciences Partners: investment, 202006 financing round Series B totalling €34m incl existing investor LSP 2020-06-16
eTheRNA–Novalis LifeSciences: investment, 202006 financing round Series B totalling €34m incl new investor Novalis LifeSciences LLC 2020-06-16
eTheRNA–Omega Funds: investment, 202006 financing round Series B totalling €34m incl existing investor Omega Funds 2020-06-16
eTheRNA–SEVERAL: investment, 202006 financing round Series B €34m from all existing + new investors 2020-06-16
eTheRNA–Yijing Capital: investment, 202006 financing round Series B totalling €34m incl new investor Yijing Capital 2020-06-16
GSK–Ideaya Biosciences: synthetic lethality, 202006– collab strategic partnership ww $100m upfront + milestones + royalties 2020-06-16
Ideaya Biosciences–GSK: investment, 202006 direct private placement $20m common stock purchase by GSK 2020-06-16
MedinCell–SEVERAL: investment, 202006 capital increase €15.6m from French + international investors 2020-06-16
Ona Therapeutics–Alta Life Sciences: investment, 202006 financing round Series A totalling €30m incl new investor Alta Life Sciences 2020-06-16
Ona Therapeutics–Asabys Partners: investment, 202006 financing round Series A totalling €30m incl existing investor Sabadell Asabys 2020-06-16
Ona Therapeutics–France (govt): investment, 202006 financing round Series A totalling €30m incl new investor Bpifrance InnoBio 2 2020-06-16
Ona Therapeutics–Fund+: investment, 202006 financing round Series A totalling €30m incl new investor Fund+ 2020-06-16
Ona Therapeutics–Optimum Strategic Communications: public relations, 202006 service existent by Optimum 2020-06-16
Ona Therapeutics–SEVERAL: investment, 202006 financing round Series A €30m 2020-06-16
Ona Therapeutics–Ysios Capital: investment, 202006 financing round Series A totalling €30m incl new investor Ysios Capital 2020-06-16
Qurient–Max Planck: proteasome inhibitors, 2012006– collab develop + license + founding of joint venture QLi5 Therapeutics GmbH 2020-06-16
CureVac–Germany (govt): investment, 202006 investment €300m direct equity investment by KfW 2020-06-15
Epsilen Bio–Sofinnova: investment, 202006c seed financing €2.3m from Sofinnova Partners through Sofinnova Telethon Fund 2020-06-15
Bit Bio–ARCH Venture: investment, 202006 financing round Series A totalling $41.5m incl co-investor Arch Venture Partners 2020-06-13
Bit Bio–BY Capital: investment, 202006 financing round Series A totalling $41.5m incl co-investor BlueYard Capital 2020-06-13
Bit Bio–Foresite Capital: investment, 202006 financing round Series A totalling $41.5m incl co-investor Foresite Capital 2020-06-13
Bit Bio–Mission Group: public relations, 202006 service existent by April Six 2020-06-13
Bit Bio–PERSON: investment, 202006 financing round Series A totalling $41.5m incl co-leadinvestor Bob Nelsen 2020-06-13
Bit Bio–PERSON: investment, 202006 financing round Series A totalling $41.5m incl co-leadinvestor Jim Tananbaum 2020-06-13
Bit Bio–PERSON: investment, 202006 financing round Series A totalling $41.5m incl co-leadinvestor Rick Klaunser 2020-06-13
Bit Bio–SEVERAL: investment, 202006 financing round Series A $41.5m led by Rick Klaunser + Bob Nelsen + Jim Tananbaum 2020-06-13
JnJ–Bavarian Nordic: vaccine, 202006– supply $13.9m manufacturing + delivery of MVA-BN Filo Ebola vaccine to Janssen Vaccines & Prevention BV 2020-06-12
Lexent Bio–Roche: investment, 202006 acquisition of Lexent Bio by Foundation Medicine 2020-06-12
Corvidia Therapeutics–Goodwin Procter: legal services, 202006 supply service legal advisor to Cordivia for acquisition by Novo Nordisk 2020-06-11
Corvidia Therapeutics–JPMorgan Chase: financial services, 202006 supply service advisor to Cordivia for acquisition by Novo Nordisk 2020-06-11
Corvidia Therapeutics–Novo Group: investment, 202006 acquisition $725m upfront cash + $1.375b milestones cash by Novo Nordisk ANNOUNCED 2020-06-11
Novo Group–Davis Polk & Wardell: legal services, 202006 supply service legal advisor to Novo Nordisk for acquisition of Corvidia Therapeutics 2020-06-11
10x Genomics–Merck (DE): CRISPR technology, 202006 collab launch integrated solution for CRISPR research 2020-06-10
Bioqube Ventures–Belgium (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor Belfius Insurance 2020-06-10
Bioqube Ventures–Belgium (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor FPIM 2020-06-10
Bioqube Ventures–EU (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor EIF 2020-06-10
Bioqube Ventures–Flanders (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor PMV 2020-06-10
Bioqube Ventures–Genmab: investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl strategic investor Genmab 2020-06-10
Bioqube Ventures–JnJ: investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl strategic investorj JnJ Innovation 2020-06-10
Bioqube Ventures–Molenwater Groep: investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor Molenwater Groep 2020-06-10
Bioqube Ventures–SEVERAL: investment, 202006 first closing €60m of Bioqube Factory Fund I investors incl EIF + PMV + FPIM + Genmab + JJDC et al 2020-06-10
Protera–SEVERAL: investment, 202006 financing round Series A $5.6m led by Sofinnova Partners + incl existing investor SOSV 2020-06-10
Ysios Capital–SEVERAL: investment, 202006 first closing €155m of Ysios BioFund III with target size of €200m 2020-06-10
Royalty Pharma–AiCuris: letermovir, 202006 acquisition of partial royalty interest on letermovir for one-time payment of $220m by Royalty Pharma 2020-06-09
Valo Therapeutics–Scius Communications: public relations, 202006 supply service existent by Scius Communications 2020-06-08
Tropic Biosciences–SEVERAL: investment, 202006 financing round Series B $28.5m led by Temasek 2020-06-04
Tropic Biosciences–Temasek: investment, 202006 financing round Series B totalling $28.5m incl new + lead investor Temasek 2020-06-04
Base Genomics–SEVERAL: investment, 202006 seed financing round £9m ($11m) led by Oxford Sciences Innovation 2020-06-03
Base Genomics–Univ Oxford: investment, 202006 seed financing round totalling £9m incl lead investor Oxford Sciences Innovation 2020-06-03
Base Genomics–Zyme Communications: public relations, 202006 service existent by Zyme 2020-06-03
BRAIN–SEVERAL: investment, 202006 private placenment €14.94m with 1.8m new shares at €8.3/share 2020-06-03
Hyloris Pharmaceuticals–SEVERAL: investment, 202006– IPO with 5m+750k shares at price range of €10.0 to €11.5 at Euronext Brussels 2020-06-03
NodThera–SEVERAL: investment, 202006 financing round Series B £44m ($55m) led by Novo Ventures 2020-06-03
Prilenia–Forbion: investment, 202006 financing round Series A totalling $62.5m incl new + lead investor Forbion 2020-06-03
Prilenia–Genworks 2: investment, 202006 financing round Series A totalling $62.5m incl existing + co-investor Genworks 2 2020-06-03
Prilenia–Instinctif Partners: public relations, 202006 service existent by Instinctif 2020-06-03
Prilenia–Morningside: investment, 202006 financing round Series A totalling $62.5m incl new + co-investor Morningside Venture Investments 2020-06-03
Prilenia–Sectoral Asset Management: investment, 202006 financing round Series A totalling $62.5m incl new + co-investor Sectoral Asset Management 2020-06-03
Prilenia–SEVERAL: investment, 202006 financing round Series A $62.5m led by new investor Forbion 2020-06-03
Prilenia–Talisman Capital Partners: investment, 202006 financing round Series A totalling $62.5m incl existing + co-investor Talisman Capital Partners 2020-06-03
AdvanceCor–Bavaria (govt): investment, 202006 financing round totalling €3.9m incl existing + co-investor Bayern Kapital 2020-06-02
AdvanceCor–First Capital Partner: investment, 202006 financing round totalling €3.9m incl co-investor First Capital Partner 2020-06-02
AdvanceCor–Germany (govt): investment, 202006 financing round totalling €3.9m incl existing + co-investor KfW Bank 2020-06-02
AdvanceCor–MIG Fonds: investment, 202006 financing round totalling €3.9m incl existing + lead investor MIG AG 2020-06-02
AdvanceCor–Occident Group: investment, 202006 financing round totalling €3.9m incl existing + co-investor Occident 2020-06-02
AdvanceCor–SEVERAL: investment, 202006 financing round €3.9m led by MIG AG 2020-06-02
Rigenerand–Image Box: public relations, 202005– supply service by Image Box PR 2020-05-29
Genmab–Rentschler: biologics contract manufacturing, 202005– collab expansion production of DuoBody products to new Rentschler US facility 2020-05-27
Kumovis–Ffilipa Venture Capital: investment, 202005 financing round Series A totalling €3.6m incl existing + co-investor Ffilipa Venture Capital 2020-05-27
Kumovis–High-Tech Gründerfonds: investment, 202005 financing round Series A totalling €3.6m incl existing + co-investor HTGF 2020-05-27
Kumovis–Renolit: investment, 202005 financing round Series A totalling €3.6m incl new + co-lead investor Renolit SE 2020-05-27
Kumovis–SEVERAL: investment, 202005 financing round Series A €3.6m led by Renolit + Solvay Ventures 2020-05-27
Kumovis–Solvay: investment, 202005 financing round Series A totalling €3.6m incl new + co-lead investor Solvay Ventures 2020-05-27
MedinCell–SEVERAL: credit, 202005– state guaranteed PGE loan €10.9m at 0.25% up to 5y from Banque Populaire du Sud + BNP Paribas 2020-05-27
Accure Therapeutics–SEVERAL: investment, 202005 financing round Series A €7.6m led by Alta Life Sciences with support from CDTI 2020-05-26
Argenx–SEVERAL: investment, 202005 global offering $862.5 via ADS offering in US + private placement in Europe 2020-05-26
Exscientia–SEVERAL: investment, 202005 financing round Series C $60m led by Novo Holdings + incl Evotec + BMS + GT Healthcare Capital 2020-05-26
Spindiag–Baden-Württemberg (govt): grant, 202004 grant €6m for Spindiag + HSI-IMIT from Ministry of Economic Affairs 2020-05-26
Spindiag–SEVERAL: investment, 202005 financing round Series B €16.3m with investors WBG Pflegeheime + Think-Health Ventures et al. 2020-05-26
Spindiag–Think.Health Ventures: investment, 202005 financing round Series B totalling €16.3m incl new investor Think.Health Ventures 2020-05-26
Spindiag–WBG Pflegeheime: investment, 202005 financing round Series B totalling €16.3m incl existing investor WBG Pflegeheime 2020-05-26
Sterna Biologicals–MC Services: public relations, 202005 service existent by MC Services 2020-05-26
Sterna Biologicals–SEVERAL: investment, 202005 private placement €12m with existing + new investors 2020-05-26
Themis Bioscience–Merck (US): investment, 202005– acquisition €na all remaing shares of Themis via Merck subsidiary 2020-05-26
Tollys–Andrew Lloyd Associates: public relations, 202005 service existent by ALA 2020-05-26
Tollys–SEVERAL: investment, 202005 financing round Series A €2.3m bringing total raised since founding 2015 to €6.4m 2020-05-26
1 2 3 ... 102 103 104  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top